These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The placebo responder rate in children and adolescents. Lewis DW; Winner P; Wasiewski W Headache; 2005 Mar; 45(3):232-9. PubMed ID: 15836598 [No Abstract] [Full Text] [Related]
44. New perspectives for nonsteroidal antiinflammatory therapy. de Brum-Fernandes AJ J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978 [No Abstract] [Full Text] [Related]
45. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases. Gibofsky A J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424 [TBL] [Abstract][Full Text] [Related]
47. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Fenn GC; Grobler M; Schaffer D Intern Med J; 2004 Nov; 34(11):647-9; discussion 650. PubMed ID: 15546461 [No Abstract] [Full Text] [Related]
48. [Individualized therapy in treatment of rheumatic diseases]. Li ZG Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2449-50. PubMed ID: 17156668 [No Abstract] [Full Text] [Related]
49. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases]. Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987 [No Abstract] [Full Text] [Related]
50. Use of nonsteroidal antiinflammatory drugs in rheumatic diseases. Spector R J Iowa Med Soc; 1981 Dec; 71(12):538-9, 542. PubMed ID: 6977004 [No Abstract] [Full Text] [Related]
57. [What shall we do with the numerous new anti-rheumatics?]. Hvidberg E Ugeskr Laeger; 1981 Apr; 143(16):1040-3. PubMed ID: 6972112 [No Abstract] [Full Text] [Related]
58. [What are the indications for non-steroidal anti-inflammatory agents in dermatology?]. Bonnetblanc JM Ann Dermatol Venereol; 1999; 126(8-9):649-52. PubMed ID: 10530363 [No Abstract] [Full Text] [Related]
59. [Findings on the causes and mechanisms in the development of undesirable effects of non-steroidal anti-rheumatic agents and their incidence in controlled clinical trials]. Pavelka K; Vojtísek D; Kañkova D; Perlík F; Pelísková Z Fysiatr Revmatol Vestn; 1982 Jan; 60(1):1-10. PubMed ID: 7040188 [No Abstract] [Full Text] [Related]
60. [Workshop 88. Perspectives on topical therapy using non-steroidal antiphlogistics/analgesics. Frankfurt/Main, 23 January 1988]. Z Rheumatol; 1988; 47(6 Suppl):1-12. PubMed ID: 3265560 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]